AARS2-Related Leukodystrophy: a Case Report and Literature Review

Cerebellum. 2023 Feb;22(1):59-69. doi: 10.1007/s12311-022-01369-5. Epub 2022 Jan 27.

Abstract

Mutations in the alanyl-transfer RNA synthase 2 (AARS2) represent a heterogenous group of autosomal recessive leukodystrophy characterized by cognitive decline, ataxia, spasticity, and Parkinsonism. AARS2-related leukodystrophy (AARS2-L) is extremely rare. To date, only 45 genetically confirmed cases, explaining the frequent diagnostic delay. Here, we report a 21-year-old male presented with unsteady gait and weakness in the bilateral lower extremities. Examination revealed dysarthria, cerebellar ataxia, paraparesis, and Parkinsonism with generalized hyperreflexia. MRI findings showed extensive white matter lesions in bilateral frontoparietal lobes, immediate periventricular regions, and corpus callosum. Focused exome sequencing revealed compound heterozygous mutations in the AARS2 gene confirming the diagnosis of AARS2-L; two heterogeneous missense mutations (c.452 T > C, p. M151T; c. 2557C > T, p. R853W) appeared together for the first time. We also reviewed phenotypic spectra of AARS2-related leukodystrophies from a total of 45 reported cases.

Keywords: Alanyl-transfer RNA synthase 2 (AARS2); Axonal spheroids and pigmented glia (ALSP); Clinical features; Gene mutation; Leukodystrophy.

Publication types

  • Review
  • Case Reports

MeSH terms

  • Adult
  • Delayed Diagnosis
  • Demyelinating Diseases*
  • Humans
  • Leukoencephalopathies* / diagnostic imaging
  • Leukoencephalopathies* / genetics
  • Magnetic Resonance Imaging
  • Male
  • Mutation
  • Mutation, Missense
  • Neurodegenerative Diseases*
  • Young Adult